Twelve candidate aging rate indicators could offer faster route to testing geroprotective drugs – and to understanding what ...

Yale-led analysis harmonized 51 studies under one standardized pipeline, and senolytics came out looking shaky.

Durham University spinout Magnitude Biosciences raises $1.3 million to scale a platform that screens drugs in living worms, ...

Cara Cassino spent a year advising Oligomerix from the boardroom. Now she’s running the company as its lead drug enters human ...

Company bets that AI-assisted analysis and a leaner trial design can get PrimeC to patients years sooner than the usual ...

PhytoGaia spotlights new clinical data on ingredients for healthy aging, liver support and, notably, pet wellness. Walk the ...

After reconsidering, Canada’s Drug Agency issued a final recommendation supporting public reimbursement of lecanemab, sold as ...

Tulu Health has launched in the US, betting that AI built for patient relationships can plug the churn draining membership clinics.

New Princeton lab gives skincare-focused biotech direct control over research behind its flagship rapalog serum, rather than ...

Phase 3 results presented in Munich and Barcelona show gains for two life-threatening conditions that quietly steal years ...

Mission Therapeutics pairs brain-penetrant mitochondria drug with NeuraLight’s eye-tracking biomarkers in a multi-country ...

Deepinder Goyal’s brain-wearable startup Temple has acquired Longevous, pulling the cofounders into full-time roles steering ...